P. Kent Hawryluk, President & CEO at MBX Biosciences, Inc. (MBX), sold 607 shares at $29.54 ($18K) on 2026-05-06, disclosed to the SEC on 2026-05-08.
Open-market sale of $18k MBX by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| MBX | BUY | 2025-02-05 | $535K | — | Filing → |
| GEMP | BUY | 2017-03-14 | $474K | — | Filing → |
| GEMP | BUY | 2016-08-12 | $250K | — | Filing → |